Abstract
Introduction: The development of Bullous pemphigoid (BP) in a patient with Psoriasis vulgaris (PV) is rare, as Bullous pemphigoid affects a different age group and its cause is not related to psoriasis. The cause of co-existence between the two diseases is still not clear and requires more reporting and review.
Case Presentation: Here, we report a case of a 55-year-old woman with a 22-year history of Psoriasis vulgaris who developed itching and blisters to all four limbs around the scaly plaques of PV. Biopsy of the lesion revealed sub-epidermal bullae and an eosinophilic inflammatory infiltrate. Immunofluorescence microscopy showed linear C3 deposition at the basement membrane zone, and the condition was diagnosed as Bullous pemphigoid. Treatment in such conditions varies among reported cases, and includes methotrexate, cyclosporine, dapsone, azathioprine, and others. In this case, methotrexate was suggested but because patient could not tolerate the course of methotrexate she was started on a combination therapy of cyclosporine 100 mg PO twice daily and tetracycline PO 500 mg PO Q 6 hourly. Both conditions showed significant improvement within 4 weeks.
Take-away lesson: As the cause of the concurrence is still unclear, the correct management for such cases still vary. The case report highlighted our experience to benefit dermatologists and physicians, with one therapeutic regimen that can benefit patients who cannot tolerate methotrexate due to its side effects.
 
Keywords: Psoriasis, Psoriasis vulgaris, Pemphigoid, Bullous pemphigoid, Linear C3 Deposition

 

» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/7386
 
Note: This case report is prepared using the CARE Checklist (2013) of information to include when writing a case report (https://www.care-statement.org). The CARE guidelines for
case reports help reduce bias, increase transparency, and provide early signals of what works, for which patients, and under which circumstance.
Air Max 95 20th AnniversaryAir Jordan

Current Issue

Volume 12, Issue 3, July-September 2020

 


 

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:


Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: